Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: June 30, 2023
Neuromodulation may be an effective option for some patients with difficult-to-treat conditions.
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: June 30, 2023
The explosion of interest in interventional psychiatry is highlighted by 2 recent reviews published in Current Psychiatry.
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: May 1, 2023
For some patients, IV medications, blocks, and injections could be effective treatments.
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: May 1, 2023
Bipolar disorder (BD) is a recurrent, life-long psychiatric illness affecting nearly 2% of the world population that is characterized by episo...
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: July 1, 2022
While our understanding of the mechanisms of psychosis continues to evolve beyond the dopamine hypothesis, the key role o...
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: November 2, 2021
Individuals with anxiety will experience frequent or chronic excessive worry, nervousness, a sense of unease, a feeling of being unfocused, and dis...
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: June 1, 2021
Lithium is one of the most widely used mood stabilizers and is considered a first-line treatment for bipolar disorder because of its proven antiman...
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: February 1, 2021
Recent evidence suggests that suvorexant, which is FDA-approved for insomnia, may be useful for preventing delirium.
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: May 1, 2020
PTSD occurs acutely and chronically in the aftermath of severe and potentially life-threatening trauma.
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: September 9, 2018
Most clinicians do not think about receptor occupancy when they prescribe a medication. Most simply assume that if they use a low dose of a medicat...
Article
- Author:
- Rif S. El-Mallakh, MD
Publish date: March 1, 2017
Dosage windows could be difficult to understand pharmacologically, but for a partial agonist the presumed mechanism could be more evident. Clinicia...
News
- Author:
- Rif S. El-Mallakh, MD
Publish date: September 29, 2015
